Spots Global Cancer Trial Database for Study Of SU011248 Versus Chemotherapy For Patients With Previously Treated Triple Receptor Negative Breast Cancer
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Study Of SU011248 Versus Chemotherapy For Patients With Previously Treated Triple Receptor Negative Breast Cancer
Official Title: A Randomized Phase 2 Study Of SU011248 Versus Standard-Of-Care For Patients With Previously Treated, Advanced, Triple Receptor Negative (ER, PR, HER2) Breast Cancer
Study ID: NCT00246571
Conditions
Study Description
Brief Summary: The purpose of this study is to compare progression free survival for SU011248 \[sutent (sunitinib malate)\] versus standard of care therapy in patients with previously treated, advanced, triple receptor negative (ER, PR, HER2) locally recurrent or metastatic breast cancer.
Detailed Description:
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Pfizer Investigational Site, Corona, California, United States
Pfizer Investigational Site, Fullerton, California, United States
Pfizer Investigational Site, Glendora, California, United States
Pfizer Investigational Site, Los Angeles, California, United States
Pfizer Investigational Site, Los Angeles, California, United States
Pfizer Investigational Site, Los Angeles, California, United States
Pfizer Investigational Site, Mission Hills, California, United States
Pfizer Investigational Site, Northridge, California, United States
Pfizer Investigational Site, Palm Springs, California, United States
Pfizer Investigational Site, Pasadena, California, United States
Pfizer Investigational Site, Pomona, California, United States
Pfizer Investigational Site, Rancho Cucamonga, California, United States
Pfizer Investigational Site, Santa Monica, California, United States
Pfizer Investigational Site, Valencia, California, United States
Pfizer Investigational Site, West Covina, California, United States
Pfizer Investigational Site, Aurora, Colorado, United States
Pfizer Investigational Site, Washington, District of Columbia, United States
Pfizer Investigational Site, Boca Raton, Florida, United States
Pfizer Investigational Site, Gainesville, Florida, United States
Pfizer Investigational Site, Atlanta, Georgia, United States
Pfizer Investigational Site, Atlanta, Georgia, United States
Pfizer Investigational Site, Decatur, Georgia, United States
Pfizer Investigational Site, Macon, Georgia, United States
Pfizer Investigational Site, Marietta, Georgia, United States
Pfizer Investigational Site, Tucker, Georgia, United States
Pfizer Investigational Site, Zion, Illinois, United States
Pfizer Investigational Site, Indianapolis, Indiana, United States
Pfizer Investigational Site, Bloomfield Hills, Michigan, United States
Pfizer Investigational Site, Brownstown, Michigan, United States
Pfizer Investigational Site, Dearborn, Michigan, United States
Pfizer Investigational Site, Detroit, Michigan, United States
Pfizer Investigational Site, West Bloomfield, Michigan, United States
Pfizer Investigational Site, Biloxi, Mississippi, United States
Pfizer Investigational Site, Clarkson Valley, Missouri, United States
Pfizer Investigational Site, St. Louis, Missouri, United States
Pfizer Investigational Site, St. Louis, Missouri, United States
Pfizer Investigational Site, Midland Park, New Jersey, United States
Pfizer Investigational Site, Morristown, New Jersey, United States
Pfizer Investigational Site, Paramus, New Jersey, United States
Pfizer Investigational Site, Pompton Plains, New Jersey, United States
Pfizer Investigational Site, Ridgewood, New Jersey, United States
Pfizer Investigational Site, Summit, New Jersey, United States
Pfizer Investigational Site, Westwood, New Jersey, United States
Pfizer Investigational Site, Bronx, New York, United States
Pfizer Investigational Site, Bronx, New York, United States
Pfizer Investigational Site, Clinton, North Carolina, United States
Pfizer Investigational Site, Goldsboro, North Carolina, United States
Pfizer Investigational Site, Wilson, North Carolina, United States
Pfizer Investigational Site, Del City, Oklahoma, United States
Pfizer Investigational Site, Greensburg, Pennsylvania, United States
Pfizer Investigational Site, Hershey, Pennsylvania, United States
Pfizer Investigational Site, Pittsburgh, Pennsylvania, United States
Pfizer Investigational Site, Pittsburgh, Pennsylvania, United States
Pfizer Investigational Site, Wexford, Pennsylvania, United States
Pfizer Investigational Site, Memphis, Tennessee, United States
Pfizer Investigational Site, Memphis, Tennessee, United States
Pfizer Investigational Site, Memphis, Tennessee, United States
Pfizer Investigational Site, Dallas, Texas, United States
Pfizer Investigational Site, Dallas, Texas, United States
Pfizer Investigational Site, Fort Worth, Texas, United States
Pfizer Investigational Site, Houston, Texas, United States
Pfizer Investigational Site, Houston, Texas, United States
Pfizer Investigational Site, Plano, Texas, United States
Pfizer Investigational Site, Plano, Texas, United States
Pfizer Investigational Site, Richardson, Texas, United States
Pfizer Investigational Site, San Antonio, Texas, United States
Pfizer Investigational Site, San Antonio, Texas, United States
Pfizer Investigational Site, San Antonio, Texas, United States
Pfizer Investigational Site, San Antonio, Texas, United States
Pfizer Investigational Site, San Atonio, Texas, United States
Pfizer Investigational Site, Tyler, Texas, United States
Pfizer Investigational Site, Federal Way, Washington, United States
Pfizer Investigational Site, Lakewood, Washington, United States
Pfizer Investigational Site, Puyallup, Washington, United States
Pfizer Investigational Site, Seattle, Washington, United States
Pfizer Investigational Site, Seattle, Washington, United States
Pfizer Investigational Site, Tacoma, Washington, United States
Pfizer Investigational Site, Sofia, , Bulgaria
Pfizer Investigational Site, Sofia, , Bulgaria
Pfizer Investigational Site, Sofia, , Bulgaria
Pfizer Investigational Site, Stara Zagora, , Bulgaria
Pfizer Investigational Site, Varna, , Bulgaria
Pfizer Investigational Site, Edmonton, Alberta, Canada
Pfizer Investigational Site, Toronto, Ontario, Canada
Pfizer Investigational Site, Brno, Ceska Republika, Czech Republic
Pfizer Investigational Site, Praha 8, Ceska Republika, Czech Republic
Pfizer Investigational Site, Brno, , Czech Republic
Pfizer Investigational Site, Praha 8, , Czech Republic
Pfizer Investigational Site, BESANCON Cedex 5, , France
Pfizer Investigational Site, BESANCON cedex, , France
Pfizer Investigational Site, NANTES cedex, , France
Pfizer Investigational Site, Paris Cedex 20, , France
Pfizer Investigational Site, Berlin, , Germany
Pfizer Investigational Site, Budapest, , Hungary
Pfizer Investigational Site, Budapest, , Hungary
Pfizer Investigational Site, Aviano (PN), , Italy
Pfizer Investigational Site, Milano, , Italy
Pfizer Investigational Site, Prato, FI, , Italy
Pfizer Investigational Site, Barcelona, , Spain
Pfizer Investigational Site, Gerona, , Spain
Pfizer Investigational Site, Lleida, , Spain
Pfizer Investigational Site, Malaga, , Spain
Pfizer Investigational Site, Sevilla, , Spain
Pfizer Investigational Site, Adana, Balcali, Turkey
Pfizer Investigational Site, Ankara, Besevler, Turkey
Pfizer Investigational Site, Istanbul, Pendik, Turkey
Pfizer Investigational Site, Ankara, Sihhiye, Turkey
Pfizer Investigational Site, Dnipropetrovsk, , Ukraine
Pfizer Investigational Site, Kyiv, , Ukraine
Pfizer Investigational Site, Odessa, , Ukraine
Pfizer Investigational Site, Edinburgh, , United Kingdom
Pfizer Investigational Site, Oxfordshire, , United Kingdom
Pfizer Investigational Site, Southampton, , United Kingdom
Contact Details
Name: Pfizer CT.gov Call Center
Affiliation: Pfizer
Role: STUDY_DIRECTOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
